Redcare Pharmacy NV (ETR:RDC)
Germany
· Delayed Price · Currency is EUR 128.40
+5.20 (4.22%)
Apr 24, 2025, 5:35 PM CET
Redcare Pharmacy NV Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 2,371 | 1,799 | 1,204 | 1,060 | 968.06 | Upgrade
|
| Revenue Growth (YoY) | 31.79% | 49.35% | 13.58% | 9.53% | 38.09% | Upgrade
|
| Cost of Revenue | 1,825 | 1,358 | 872.57 | 793.53 | 748.53 | Upgrade
|
| Gross Profit | 545.78 | 440.38 | 331.79 | 266.8 | 219.53 | Upgrade
|
| Selling, General & Admin | 581.07 | 444.49 | 379.17 | 299.21 | 214.04 | Upgrade
|
| Other Operating Expenses | -0.35 | -0.32 | -0.15 | -0.16 | -0.07 | Upgrade
|
| Operating Expenses | 580.73 | 444.18 | 379.02 | 299.05 | 213.97 | Upgrade
|
| Operating Income | -34.95 | -3.79 | -47.23 | -32.25 | 5.56 | Upgrade
|
| Interest Expense | -7.78 | -8 | -8.5 | -8.57 | -10.76 | Upgrade
|
| Interest & Investment Income | 6.4 | 4.61 | - | - | - | Upgrade
|
| Earnings From Equity Investments | 0.42 | 0.23 | 0.34 | -0.43 | 0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.52 | 0.28 | 1.76 | 1.49 | -0.23 | Upgrade
|
| Other Non Operating Income (Expenses) | -8.37 | -7.02 | -6.97 | -4.53 | -3.72 | Upgrade
|
| EBT Excluding Unusual Items | -43.76 | -13.7 | -60.6 | -44.28 | -9.11 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.32 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -1.58 | -0.16 | -0.4 | Upgrade
|
| Other Unusual Items | -4.08 | -0.65 | -21.62 | -33.45 | -6.42 | Upgrade
|
| Pretax Income | -47.83 | -14.35 | -84.12 | -77.88 | -15.93 | Upgrade
|
| Income Tax Expense | -1.48 | -2.74 | -6.47 | -3.7 | 0.84 | Upgrade
|
| Earnings From Continuing Operations | -46.36 | -11.61 | -77.65 | -74.19 | -16.77 | Upgrade
|
| Minority Interest in Earnings | 0.89 | -0.44 | - | - | - | Upgrade
|
| Net Income | -45.46 | -12.04 | -77.65 | -74.19 | -16.77 | Upgrade
|
| Net Income to Common | -45.46 | -12.04 | -77.65 | -74.19 | -16.77 | Upgrade
|
| Shares Outstanding (Basic) | 20 | 19 | 18 | 18 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 19 | 18 | 18 | 14 | Upgrade
|
| Shares Change (YoY) | 4.24% | 6.97% | 0.57% | 24.37% | 10.07% | Upgrade
|
| EPS (Basic) | -2.27 | -0.63 | -4.32 | -4.15 | -1.17 | Upgrade
|
| EPS (Diluted) | -2.27 | -0.63 | -4.32 | -4.15 | -1.17 | Upgrade
|
| Free Cash Flow | 13.38 | 55.02 | -42.68 | -2.18 | -20.43 | Upgrade
|
| Free Cash Flow Per Share | 0.67 | 2.86 | -2.37 | -0.12 | -1.42 | Upgrade
|
| Gross Margin | 23.02% | 24.48% | 27.55% | 25.16% | 22.68% | Upgrade
|
| Operating Margin | -1.47% | -0.21% | -3.92% | -3.04% | 0.57% | Upgrade
|
| Profit Margin | -1.92% | -0.67% | -6.45% | -7.00% | -1.73% | Upgrade
|
| Free Cash Flow Margin | 0.56% | 3.06% | -3.54% | -0.21% | -2.11% | Upgrade
|
| EBITDA | -12.83 | 14.47 | -34 | -21.6 | 12.8 | Upgrade
|
| EBITDA Margin | -0.54% | 0.80% | -2.82% | -2.04% | 1.32% | Upgrade
|
| D&A For EBITDA | 22.12 | 18.27 | 13.23 | 10.65 | 7.24 | Upgrade
|
| EBIT | -34.95 | -3.79 | -47.23 | -32.25 | 5.56 | Upgrade
|
| EBIT Margin | -1.47% | -0.21% | -3.92% | -3.04% | 0.57% | Upgrade
|
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.